Literature DB >> 7771648

Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men.

L G Carr1, J Y Hartleroad, Y Liang, C Mendenhall, T Moritz, H Thomasson.   

Abstract

Because alcoholic hepatitis and cirrhosis, well-known complications of alcohol abuse, do not occur in all alcoholics, genetic factors such as differences in alcohol-metabolizing enzymes may play a role in the development of alcoholic liver disease. Cytochrome P450IIE1 catalyzes the oxidation of ethanol, producing acetaldehyde and free radicals capable of reacting with and peroxidizing cell membranes. Polymorphisms have been identified in the 5'-flanking region of the P450IIE1 gene that may alter the transcriptional activity of the gene. In this study, we analyzed the P450IIE1 genotypes at the polymorphic PstI and RsaI restriction enzyme sites in 53 Caucasians with severe alcoholic liver disease to determine if there is an association between these polymorphisms and alcoholic liver disease. Subjects that tested positive for the hepatitis C virus were eliminated from the study. To identify the type A (homozygous for the c1 gene), type B (heterozygous for the c1 and c2 genes), and type C (homozygous for the c2 gene) genotypes at the P450IIE1 locus, DNA encompassing the polymorphisms was amplified by polymerase chain reaction, slot-blotted, and probed with allele-specific oligonucleotides. Allele frequencies for the c1 allele were 0.95 for alcoholics with severe liver disease, 0.95 for alcoholics without liver disease, and 0.98 for the general population. No differences in allele frequencies between alcoholic patients with severe liver disease and alcoholics without liver disease were observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771648     DOI: 10.1111/j.1530-0277.1995.tb01489.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  11 in total

1.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Authors:  N A Wong; F Rae; K J Simpson; G D Murray; D J Harrison
Journal:  Mol Pathol       Date:  2000-04

2.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Authors:  S Liu; J Y Park; S P Schantz; J C Stern; P Lazarus
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

3.  Genetic polymorphisms in alcohol metabolizing enzymes as related to sensitivity to alcohol-induced health effects.

Authors:  H Tanaka; E Ikai; Y Yamada
Journal:  Environ Health Prev Med       Date:  1997-01       Impact factor: 3.674

4.  Effects of genetic polymorphisms in alcohol-metabolizing enzymes on alcohol hypersensitivity and alcohol-related health problems in orientals.

Authors:  T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  1996-04       Impact factor: 3.674

Review 5.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

6.  Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.

Authors:  C Meiler; M Muhlbauer; M Johann; A Hartmann; B Schnabl; N Wodarz; G Schmitz; J Scholmerich; C Hellerbrand
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

7.  Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease.

Authors:  J Grove; A K Daly; M F Bassendine; E Gilvarry; C P Day
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

8.  Cytochrome P450 2E1 high activity polymorphism in alcohol abuse and end-organ disease.

Authors:  Mark T Cartmell; Hans-Ulrich Schulz; Derek A O'Reilly; Bing-Mei Yang; Volker Kielstein; Simon P Dunlop; Walter Halangk; Andrew G Demaine; Andrew N Kingsnorth
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

9.  RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma.

Authors:  J M Ladero; J A Agúndez; A Rodríguez-Lescure; M Diaz-Rubio; J Benítez
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

10.  Polymorphisms of ethanol-oxidizing enzymes in alcoholics with inactive ALDH2.

Authors:  S Higuchi; T Muramatsu; S Matsushita; M Murayama; M Hayashida
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.